<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shan, Sam</style></author><author><style face="normal" font="default" size="100%">Seaton, Kate</style></author><author><style face="normal" font="default" size="100%">Basnayake, Chamara</style></author><author><style face="normal" font="default" size="100%">Ross, Laura</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Underrecognition of Fecal Incontinence in Systemic Sclerosis: Discrepancies Between the Rome IV Diagnostic Questionnaires and the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire</style></title><secondary-title><style face="normal" font="default" size="100%">The Journal of Rheumatology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2026-02-15 04:00:30</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">jrheum.2025-1226</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.3899/jrheum.2025-1226</style></doi><volume><style face="normal" font="default" size="100%"></style></volume><issue><style face="normal" font="default" size="100%"></style></issue><abstract><style  face="normal" font="default" size="100%">Gastrointestinal (GI) involvement in systemic sclerosis (SSc) is common, with up to 87% of people affected.1 Of all SSc manifestations, GI disease has the greatest impact on quality of life.2</style></abstract></record></records></xml>